Wed, Aug 27, 2014, 10:12 AM EDT - U.S. Markets close in 5 hrs 48 mins

Recent

% | $
Quotes you view appear here for quick access.

RXi Pharmaceuticals Corporation Message Board

  • sumtin14nic sumtin14nic Feb 14, 2013 4:19 PM Flag

    Buyout candidate?

    The market for scar prevention therapies is well over $1 billion in annual revenues, which makes the $18 million valuation of RXII attractive for buy-and-hold investors that have confidence in RNAi. RXi may also be a good buyout target for larger pharmaceutical companies that are looking to expand their profile in RNAi based therapeutics, since it is much cheaper than the likes of SRPT.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
RXII
2.55+0.01(+0.39%)9:58 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.